Bioxcel therapeutics to host igalmi™ commercial day on october 18, 2022

New haven, conn., oct. 05, 2022 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will host a commercial day presentation for the investment community to provide an update on its recently launched product, igalmi™ (dexmedetomidine) sublingual film, on tuesday, october 18, 2022 beginning at 11:00 a.m. eastern time.
BTAI Ratings Summary
BTAI Quant Ranking